Clinical outcomes of CyberKnife stereotactic body radiotherapy for peripheral stage I non-small cell lung cancer

The aim of this study was to evaluate the clinical outcome of CyberKnife stereotactic body radiotherapy (SBRT) for patients with stage I non-small cell lung cancer (NSCLC). Fifty patients with peripheral stage I NSCLC who refused surgery or were medically inoperable were treated with 48–60 Gy (media...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Ze-Tian, Wu, Xin-Hu, Li, Bing, Zhu, Xi-Xu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2015
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4312559/
https://www.ncbi.nlm.nih.gov/pubmed/25638468
http://dx.doi.org/10.1007/s12032-015-0506-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4312559/
https://www.ncbi.nlm.nih.gov/pubmed/25638468
http://dx.doi.org/10.1007/s12032-015-0506-1

Ejemplares similares